[Severe myalgias: an unusual undesirable effect of levamisole combined with 5-fluorouracil].
Buecher
B
B
Blanc
J F
JF
Magnien
F
F
Bechade
D
D
Lapprand
M
M
Oddes
B
B
D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery; D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007978:Levamisole / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*
D000276:Adjuvants, Immunologic; D000964:Antimetabolites, Antineoplastic; D007978:Levamisole; D005472:Fluorouracil
Des myalgies sévères: un effet indésirable inhabituel du iévamisoleassocié au 5-fluorouracile.